14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $5.34 $19.02 Monday, 6th May 2024 CNTA stock ended at $9.25. This is 2.32% less than the trading day before Friday, 3rd May 2024. During the day the stock fluctuated 2.81% from a day low at $9.24 to a day high of $9.50.
90 days $17.30 $19.02
52 weeks $16.32 $20.85

Historical Centessa Pharmaceuticals Limited prices

Date Open High Low Close Volume
Jan 18, 2024 $8.05 $8.05 $7.51 $7.63 58 650
Jan 17, 2024 $7.23 $8.00 $7.23 $7.96 145 415
Jan 16, 2024 $7.13 $7.30 $6.95 $7.30 82 976
Jan 12, 2024 $6.92 $7.26 $6.87 $7.10 338 579
Jan 11, 2024 $6.91 $7.30 $6.65 $6.91 193 332
Jan 10, 2024 $7.29 $7.62 $6.90 $6.97 74 110
Jan 09, 2024 $6.95 $7.57 $6.89 $7.30 141 813
Jan 08, 2024 $6.72 $7.33 $6.72 $7.10 234 173
Jan 05, 2024 $7.28 $7.53 $6.70 $6.73 297 589
Jan 04, 2024 $7.82 $8.03 $7.28 $7.29 243 631
Jan 03, 2024 $8.03 $8.09 $7.62 $7.82 17 890
Jan 02, 2024 $8.01 $8.20 $7.71 $8.03 71 231
Dec 29, 2023 $7.98 $8.18 $7.90 $7.96 58 779
Dec 28, 2023 $7.99 $8.50 $7.98 $8.03 320 290
Dec 27, 2023 $8.00 $8.10 $7.90 $7.99 326 953
Dec 26, 2023 $8.05 $8.05 $7.85 $7.95 56 354
Dec 22, 2023 $7.56 $8.23 $7.48 $8.00 83 714
Dec 21, 2023 $7.57 $7.59 $7.21 $7.42 32 458
Dec 20, 2023 $7.69 $8.17 $7.31 $7.43 147 006
Dec 19, 2023 $6.88 $7.75 $6.88 $7.70 145 201
Dec 18, 2023 $7.02 $7.42 $6.83 $6.88 97 413
Dec 15, 2023 $7.11 $7.66 $6.83 $7.11 158 336
Dec 14, 2023 $6.80 $7.20 $6.80 $7.00 228 129
Dec 13, 2023 $6.49 $6.71 $6.40 $6.65 120 421
Dec 12, 2023 $6.33 $6.59 $6.15 $6.40 100 137
Click to get the best stock tips daily for free!

About Centessa Pharmaceuticals Limited

Centessa Pharmaceuticals Limited Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; and SerpinPC, an activated protein C inhibitor, which is in Phase IIa clinical development for the treatm... CNTA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT